1 Answers
72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut. The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
4 views
Answered